Escalating Middle East Two-Front War... Oil Prices Break $100 | Bulk Carriers and Tankers Pushed by China, Made in India... HD Hyundai's Third Overseas Yard | Kwon Soon-woo, 3PRO TV Reporting Team Leader [News3]

Escalating Middle East's Two-Front Brawl…Oil Price Breaks $100 | Bulk Carriers and Tankers Pushed by China, Made in India…HD Hyundai's 'Third Overseas Yard' | Kwon Soon-woo, 3PRO TV Reporting Team Leader [News3]
Watch on YouTube ↗  |  September 09, 2026 at 23:29  |  34:16  |  3PRO TV (삼프로TV)
Speakers
Kwon Soon-woo — Reporting Team Lead, 3PRO TV

Summary

Kwon Soon-woo reviews escalating Middle East oil risks, Korea's Hormuz diplomatic burden, and shipbuilding/defense industry developments. He highlights Hanwha Ocean's Thailand and US defense shipbuilding momentum, HD Hyundai Heavy Industries' low-cost India expansion, Samsung Heavy's floating data center catalyst, and Korean pipe-fitting suppliers tied to US EPC projects. He also warns on KOSDAQ biotech IPO speculation and outlines a preference for info-rich, big-pharma-partnered biotech names.

  • Brent briefly topped $100 and WTI rose to $93 as Houthi-Saudi fighting escalated around key oil chokepoints.
  • Natural gas prices are expected to rise because Europe has not secured enough supply.
  • Hanwha Ocean was selected as preferred bidder for Thailand's next-generation frigate program.
  • Hanwha Ocean is pursuing US naval work via Philly Shipyard and Austal USA.
  • HD Hyundai Heavy Industries is building a low-cost India shipbuilding base to compete with China in containers and tankers.
  • Samsung Heavy Industries is marketing floating data center projects as a potential sector catalyst.
  • Korean pipe-fitting names such as Taekwang and Sungkwang Bend may follow US EPC projects.
  • KOSDAQ biotech IPOs often fade after listing, so investors should avoid unvalidated stories and favor big-pharma-partnered names.
Ideas
Kwon Soon-woo Reporting Team Lead, 3PRO TV 1:07
Oil biased up on Middle East risk.
Escalating Houthi-Saudi fighting around the Bab el-Mandeb and Hormuz chokepoints pushed Brent above $100 intraday and WTI to $93; oil watchers are discussing $120–150 by year-end because a Hormuz disruption could block Kuwait, UAE, Qatar, Bahrain and Saudi exports, with Saudi east-west pipelines only partially offsetting the risk.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 5:00
Natural gas to rise on European shortage.
Europe has not secured enough natural gas supply, so natural gas prices are expected to keep rising; this adds a separate energy-cost pressure alongside the oil shock.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 13:20
Hanwha Ocean wins Thai frigate preferred bid.
Hanwha Ocean was selected as preferred bidder for the Thai Royal Navy's next-generation frigate program; special-purpose defense vessels tend to generate repeat orders once a naval relationship and military exchanges are established, and Hanwha Ocean previously delivered Thailand's first frigate in 2018.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 14:55
HD Hyundai Heavy expands low-cost Indian shipbuilding.
HD Hyundai Heavy Industries is accelerating a third overseas shipbuilding base in India after Vietnam and the Philippines, to use India's $3–4/hour labor and 15–25% government shipbuilding subsidies to challenge China in container and tanker orders, since Korean yards cannot win bulk/container orders domestically.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 17:49
Samsung Heavy floating data center catalyst.
Samsung Heavy Industries is doing MRO in India and actively marketing floating data center projects; a first floating data center order would immediately heat up the shipbuilding/offshore sector and its related equipment chain.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 18:08
Korean pipe fittings follow US EPC projects.
Korean pipe fitting and shipbuilding equipment suppliers such as Taekwang and Sungkwang Bend are Tier 1 vendors to EPC contractors and would follow US investment-funded construction projects immediately; the market is already trading them as a US EPC/shipbuilding theme, with some names up about 20% in days.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 21:39
Avoid unvalidated biotech; favor big-pharma partners.
Kwon warns that most newly listed KOSDAQ biotech IPO names pop and then fall below issue price and fade; he advises avoiding undisclosed, secret-tip stories and Phase 3 assets with no big pharma licensing, while favoring biotech names with abundant public information and global big-pharma partnerships, because those are the ones producing real licensing-driven moves.
Kwon Soon-woo Reporting Team Lead, 3PRO TV 21:39
Avoid unvalidated biotech; favor big-pharma partners.
Kwon warns that most newly listed KOSDAQ biotech IPO names pop and then fall below issue price and fade; he advises avoiding undisclosed, secret-tip stories and Phase 3 assets with no big pharma licensing, while favoring biotech names with abundant public information and global big-pharma partnerships, because those are the ones producing real licensing-driven moves.
Up Next

This 3PRO TV (삼프로TV) video, published September 09, 2026, features Kwon Soon-woo discussing BNO, WTI, UNG, 042660.KS, 329180.KS, 010140.KS, 108860, Taekwang, KOSDAQ biotech IPOs, Korean biotech with global big pharma partnerships. 8 trade ideas extracted by AI with direction and confidence scoring.

Speakers: Kwon Soon-woo  · Tickers: BNO, WTI, UNG, 042660.KS, 329180.KS, 010140.KS, 108860, Taekwang, KOSDAQ biotech IPOs, Korean biotech with global big pharma partnerships